GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
96 hedge funds and large institutions have $571M invested in GenMark Diagnostics, Inc in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-3
Holders Change %
-3.03%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
45
Reduced
18
Closed
16
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$59K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$15.8M |
| 2 |
CC
Casdin Capital
New York
|
+$7.85M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$5.81M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.37M |
| 5 |
PCM
Penn Capital Management
Philadelphia,
Pennsylvania
|
+$3.35M |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$8.17M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$3.37M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$2.46M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.38M |
| 5 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$2.1M |
